Sangamo Therapeutics, Inc. (SGMO)
OTCMKTS · Delayed Price · Currency is USD
0.1700
+0.0050 (3.03%)
At close: Jun 16, 2026
Sangamo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -123.33 | -122.93 | -97.94 | -257.83 | -192.28 | -178.29 |
Depreciation & Amortization | 6.56 | 7.6 | 9.36 | 22.19 | 20.56 | 17.64 |
Loss (Gain) From Sale of Assets | - | - | -1.03 | - | - | - |
Asset Writedown & Restructuring Costs | 13.24 | 13.24 | 5.52 | 155.01 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | -2.33 | -1.24 | 2.84 |
Stock-Based Compensation | 7.48 | 9.08 | 12.38 | 27.36 | 31.65 | 32.96 |
Other Operating Activities | 0.03 | 0.03 | 0.06 | -5.22 | - | -6.51 |
Change in Accounts Receivable | -0.51 | 0.16 | 0.4 | 2.76 | 2.34 | -0.79 |
Change in Accounts Payable | 3.51 | 2.79 | -14.17 | 5.59 | 13.35 | -7.66 |
Change in Unearned Revenue | -7.15 | -6.66 | 13.43 | -161.16 | -91.33 | -84.2 |
Change in Income Taxes | - | - | 0.56 | -3.73 | - | - |
Change in Other Net Operating Assets | 5.32 | -0.52 | 4.29 | -7.49 | -6.67 | -9.24 |
Operating Cash Flow | -90.34 | -97.21 | -67.14 | -224.84 | -223.63 | -233.25 |
Capital Expenditures | -0.12 | -0.1 | -0.27 | -21.16 | -20.17 | -23.28 |
Sale of Property, Plant & Equipment | - | - | 1.95 | - | - | - |
Cash Acquisitions | - | - | - | - | - | -0.12 |
Investment in Securities | - | - | 35.84 | 174.69 | 79.46 | 271.6 |
Investing Cash Flow | -0.12 | -0.1 | 37.52 | 153.53 | 59.29 | 248.2 |
Issuance of Common Stock | 90.73 | 74.01 | 29.28 | 16.04 | 86.76 | 36.12 |
Repurchase of Common Stock | -1.42 | -3.26 | -0.9 | -1.45 | -2.1 | -3.26 |
Financing Cash Flow | 89.31 | 70.75 | 28.38 | 14.59 | 84.66 | 32.86 |
Foreign Exchange Rate Adjustments | 2.05 | 4.09 | -2.05 | 1.48 | 1.25 | -0.26 |
Net Cash Flow | 0.91 | -22.47 | -3.29 | -55.24 | -78.43 | 47.54 |
Free Cash Flow | -90.46 | -97.31 | -67.41 | -246 | -243.8 | -256.53 |
Free Cash Flow Margin | -261.76% | -246.03% | -116.62% | -139.59% | -219.05% | -231.73% |
Free Cash Flow Per Share | -0.28 | -0.35 | -0.33 | -1.41 | -1.58 | -1.77 |
Levered Free Cash Flow | -48.58 | -56.76 | -38.03 | -98.11 | -110.51 | -107.24 |
Unlevered Free Cash Flow | -48.58 | -56.76 | -38.03 | -98.11 | -110.51 | -107.24 |
Change in Working Capital | 5.7 | -4.22 | 4.51 | -164.03 | -82.32 | -101.9 |